Leveraging Innovation To Deliver Precision Medicines



Applying an advanced, powerful discovery engine for novel target discovery and candidate selection


Unlocking the value of first-in-class and technically challenging drug targets

Disease Focus

Gene location/fusion protein
Driver mutations
Target overexpression
Synthetic lethality

Clinical Impact
Address tumors with specific genetic mutations
Sensitize cancers to standard of care
Overcome resistance

First-in-class/innovator status
Fast-track/breakthrough potential
Rapid path to patients and value

Differentiated portfolio advancing towards Phase 1: multiple pre-clinical programs against validated targets considered intractable by conventional discovery approaches

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.